Early high-dose immunosuppression in Henoch–Schönlein nephrotic syndrome may improve outcome

References

• Singh, Devidayal S, Kumar L, Joshi K, Minz RW, Datta U. Severe Henoch–Schönlein nephritis resolution with azathioprine and steroids. Rheumatol Int 2002; 22: 133–7
   PubMed Web of Science ®Google Scholar
• Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch–Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethic origins. Lancet 2002; 360: 1197–202
   PubMed Web of Science ®Google Scholar
• Shenoy M, Bradbury MG, Lewis MA, Webb NJA. Outcome of Henoch–Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 2007; 22: 1717–22
   PubMed Web of Science ®Google Scholar
• Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein–Henoch purpura nephritis in children. Pediatr Nephrol 1999; 13: 816–23
   PubMed Web of Science ®Google Scholar
• Tarshish P, Bernstein J, Edelmann CM. Henoch–Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004; 19: 51–6
   PubMed Web of Science ®Google Scholar
• Meadow SR, Glascow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS. Schönlein–Henoch nephritis. Q J Med 1972; 41: 241–58
   PubMedGoogle Scholar
• Goldstein AR, White RHR, Akuse R, Chantler C. Long term follow-up of childhood Henoch–Schönlein nephritis. Lancet 1992; 339: 280–2
   PubMed Web of Science ®Google Scholar
• Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch–Schönlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993–1003
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch–Schönlein glomerulonephritis. Pediatr Nephrol 2003; 18: 1138–42
   PubMed Web of Science ®Google Scholar
• Flynn JT, Smoyer WE, Brunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch–Schönlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001; 21: 128–33
   PubMed Web of Science ®Google Scholar
• Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein–Henoch purpura nephritis. Pediatr Nephrol 1998; 12: 238–43
   PubMed Web of Science ®Google Scholar
• Dixit MP, Dixit NM, Scott K. Managing Henoch–Schonlein purpura in children with fish oil and ACE inhibitor therapy. Nephrology 2004; 9: 381–6
   PubMed Web of Science ®Google Scholar
• Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch–Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007; 22: 1167–71
   PubMed Web of Science ®Google Scholar
• Loeffler K, Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Pediatr Nephrol 2004; 19: 281–7
   PubMed Web of Science ®Google Scholar
• Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant 2008; 23: 910–3
   PubMed Web of Science ®Google Scholar
• Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006; 65: 936–41
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114((2 Suppl 4th Report)):555–76.
   PubMed Web of Science ®Google Scholar
• Schwartz GJ, Haycock GB, Edelmann CM, Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259–63
   PubMed Web of Science ®Google Scholar
• Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch–Schönlein nephritis. Pediatr Nephrol 2007; 22: 64–70
   PubMed Web of Science ®Google Scholar
• Saulsbury FT. Henoch–Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine 1999; 78: 395–409
   PubMed Web of Science ®Google Scholar
• Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, et al. Prognosis of Henoch–Schönlein nephritis in children. Br Med J 1977; ii: 11–4
   Google Scholar
• Rieu P, Noël LH. Henoch–Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne 1999; 150: 151–9
   PubMedGoogle Scholar
• Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Factors affecting histological regression of crescentic Henoch–Schönlein nephritis in children. Pediatr Nephrol 2006; 21: 54–9
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet 2002; 360: 666–70
   PubMed Web of Science ®Google Scholar
• Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003; 18: 347–50
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch–Schönlein glomerulonephritis. Pediatr Nephrol 2003; 18: 1138–42
   PubMed Web of Science ®Google Scholar
• Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, et al. Cyclosporin A therapy for severe Henoch–Schönlein nephritis with nephrotic syndrome. Pediatr Nephrol 2005; 20: 1093–7
   PubMed Web of Science ®Google Scholar
• Coppo R, Amore A, Peruzzi L, Mancuso D, Camilla R. Angiotensin antagonists and fish oil for treating IgA nephropathy. Contrib Nephrol 2007; 157: 27–36
   PubMed Web of Science ®Google Scholar
• Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome – a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol 2008; 23: 1483–93
   PubMed Web of Science ®Google Scholar